Therefore, currently available evidence demonstrates that serum NT-proBNP concentration in very preterm infants in the first 10 days of life could reliably predict the development of BPD or death with high sensitivity and specificity regardless of the presence of PDA. Here, NPPB is linked to bronchopulmonary dysplasia.